Cahaba Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Sell
2,280
-121
-5% -$14K 0.02% 125
2025
Q4
$253K Sell
2,401
-554
-19% -$52K 0.02% 131
2025
Q3
$248K Buy
2,955
+158
+6% +$13K 0.02% 135
2025
Q2
$221K Sell
2,797
-352
-11% -$28K 0.02% 148
2025
Q1
$283K Buy
3,149
+119
+4% +$11.1K 0.02% 118
2024
Q4
$301K Sell
3,030
-26
-0.9% -$2.68K 0.02% 115
2024
Q3
$347K Sell
3,056
-126
-4% -$15K 0.03% 109
2024
Q2
$394K Sell
3,182
-274
-8% -$35.3K 0.03% 99
2024
Q1
$456K Buy
3,456
+7
+0.2% +$863 0.04% 91
2023
Q4
$376K Buy
3,449
+456
+15% +$47.3K 0.04% 93
2023
Q3
$308K Sell
2,993
-386
-11% -$41.6K 0.03% 105
2023
Q2
$390K Sell
3,379
-44
-1% -$5K 0.04% 91
2023
Q1
$364K Sell
3,423
-38
-1% -$4.1K 0.04% 96
2022
Q4
$384K Sell
3,461
-24
-0.7% -$2.45K 0.05% 92
2022
Q3
$300K Sell
3,485
-13
-0.4% -$1.16K 0.04% 103
2022
Q2
$318K Buy
3,498
+625
+22% +$55.4K 0.05% 103
2022
Q1
$254K Buy
2,873
+194
+7% +$15.3K 0.03% 125
2021
Q4
$205K Buy
+2,679
New +$213K 0.03% 139

Other funds holding MRK

Cahaba Wealth Management's MRK Position: Q1 2026 in Review

Cahaba Wealth Management reduced its Merck (MRK) stake by 5% in Q1 2026, selling an estimated $14K and leaving 2,280 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #125.

Cahaba Wealth Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $456K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cahaba Wealth Management held 2,280 shares of Merck worth $274K as of Q1 2026.
  • Cahaba Wealth Management sold 121 Merck shares in Q1 2026, an estimated $14K.
  • Merck made up 0.02% of Cahaba Wealth Management's portfolio in Q1 2026, its #125 holding.
  • Cahaba Wealth Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Cahaba Wealth Management's Merck position peaked at $456K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cahaba Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.